Overview
Scott syndrome encompasses two distinct genetic disorders: Baratela-Scott syndrome (BSS) and Aarskog-Scott syndrome (ASS). BSS is characterized by short stature, facial dysmorphisms, developmental delay, and skeletal dysplasia due to XYLT1 gene alterations, while ASS involves facial, skeletal, and genital anomalies, notably penoscrotal transposition in males and analogous genital anomalies in females.Diagnosis
Baratela-Scott Syndrome (BSS):
- Biallelic pathogenic variants in XYLT1 identified through standard sequencing 1.
- Aberrant hypermethylation in exon 1 of XYLT1 detected via bisulfite sequencing 1.
- GGC repeat expansion in the XYLT1 promoter region confirmed by Southern blot and repeat expansion analysis 1.
Aarskog-Scott Syndrome (ASS):
- X-linked inheritance pattern 2.
- Clinical features include facial dysmorphism, skeletal abnormalities, and genital anomalies such as penoscrotal transposition in males 2.
- Female counterparts may exhibit clitoral transposition 2.Management
Baratela-Scott Syndrome (BSS):
- No specific pharmacological treatments mentioned; management focuses on supportive care addressing developmental delays and skeletal dysplasia 1.
Aarskog-Scott Syndrome (ASS):
- Management primarily supportive, addressing specific clinical manifestations such as orthopedic and urological issues 2.
- No specific drug classes or doses detailed 2.Special Populations
Pediatrics: Developmental support and early intervention programs crucial for BSS 1.
Comorbidities: Specific management strategies for skeletal dysplasia and developmental delays are essential in pediatric patients with BSS 1.Key Recommendations
Perform comprehensive genetic testing including sequencing of XYLT1 and analysis for GGC repeat expansions and exon 1 methylation for diagnosing BSS 1 (Evidence: Strong).
Consider bisulfite sequencing to detect aberrant methylation in XYLT1 exon 1 when standard sequencing methods are inconclusive in BSS 1 (Evidence: Moderate).
For ASS, genetic counseling is recommended due to its X-linked inheritance pattern, especially in families with affected males 2 (Evidence: Expert opinion).References
1 LaCroix AJ, Stabley D, Sahraoui R, Adam MP, Mehaffey M, Kernan K et al.. GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome. American journal of human genetics 2019. link
2 Moraes SG, Guerra-Junior G, Maciel-Guerra AT. Female counterpart of shawl scrotum in Aarskog-Scott syndrome. International braz j urol : official journal of the Brazilian Society of Urology 2006. link